Earnings History Data for TRACON Pharmaceuticals, Inc. (TCON) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
TRACON Pharmaceuticals, Inc.
TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company's product candidate includes TRC105, TRC205 and TRC102 which are in different clinical stage for cancer, age-related macular degeneration and fibrotic diseases. TRACON Pharmaceuticals, Inc. is headquartered in San Diego, California.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14-05-2024 | AH | TCON | TRACON Pharmaceuticals, Inc. | 4.39 | -1.33 | -1.20 | -7.20 | Tracon GAAP EPS of -$1.33 misses by $0.15, revenue of $0.1M [5/14/2024 4:03 PM] |
1.63 | -0.34 (-17.26%) |
1.60 | -0.37 (-18.78%) |
1.51 - 14.75 | 170,275 | 180,000 | 22,655 | ||
05-03-2024 | AH | TCON | TRACON Pharmaceuticals | 6.00 | 0.01 | -0.03 | 0.00 | Tracon GAAP EPS of -$0.01 beats by $0.06, revenue of $3M beats by $1.5M [3/5/2024 4:04 PM] |
0.1986 | 0.01 (5.92%) |
0.20 | 0.01 (6.67%) |
0.13 - 2.19 | 2,238,560 | 880,000 | 277,808 | ||
09-11-2023 | AH | TCON | TRACON Pharmaceuticals, Inc. | 4.60 | 0.29 | 0.00 | -0.30 | Tracon GAAP EPS of $0.29 [11/9/2023 4:03 PM] |
0.2250 | 0.06 (40.62%) |
0.30 | 0.14 (89.38%) |
0.13 - 2.19 | 53,463,496 | 1,980,000 | 19,603,460 | ||
14-08-2023 | AH | TCON | TRACON Pharmaceuticals, Inc. | 8.07 | -0.06 | -0.36 | -0.31 | Tracon GAAP EPS of -$0.20 misses by $0.17, revenue of $9M [8/14/2023 4:55 PM] |
0.2653 | -0.02 (-8.23%) |
0.29 | 0.0 (0.35%) |
0.25 - 2.32 | 837,782 | 1,020,000 | 3,908 | ||
10-05-2023 | AH | 4:00 PM ET (May 10) |
TCON | TRACON Pharmaceuticals, Inc. | 17.40 | -0.36 | -0.29 | -0.48 | Tracon GAAP EPS of -$0.36 misses by $0.09 [5/10/2023 4:50 PM] |
0.6789 | -0.03 (-4.38%) |
0.70 | -0.01 (-1.39%) |
0.63 - 2.32 | 211,598 | 140,000 | 7,064 | |
08-03-2023 | AH | 4:00 PM ET (Mar 8) |
TCON | TRACON Pharmaceuticals, Inc. | 37.76 | -0.31 | -0.28 | -0.40 | Tracon GAAP EPS of -$0.31 in-line [3/8/2023 4:31 PM] |
1.32 | -0.06 (-4.35%) |
0.0 | 0.0 (0.00%) |
1.10 - 3.00 | 153,344 | 50,000 | 0 | |
14-11-2022 | PM | 4:00 PM ET (Nov 14) |
TCON | TRACON Pharmaceuticals, Inc. | 31.28 | -0.30 | -0.30 | -0.38 | Tracon GAAP EPS of -$0.30 beats by $0.02 [11/15/2022 2:48 AM] |
1.53 | -0.16 (-9.47%) |
1.68 | -0.01 (-0.59%) |
1.24 - 3.79 | 105,535 | 100,000 | 2,130 | |
10-08-2022 | AH | 4:00 PM ET (Aug 10) |
TCON | TRACON Pharmaceuticals, Inc. | 35.81 | -0.31 | -0.29 | -0.58 | Tracon GAAP EPS of -$0.31 beats by $0.05, revenue of $0M [8/10/2022 5:54 PM] |
2.12 | 0.05 (2.42%) |
2.14 | 0.07 (3.38%) |
1.24 - 4.49 | 103,551 | 50,000 | 1,337 | |
|
||||||||||||||||||
11-05-2022 | AH | 4:00 PM ET (May 11) |
TCON | TRACON Pharmaceuticals, Inc. | 34.37 | -0.48 | -0.41 | -0.33 | Tracon GAAP EPS of -$0.48 misses by $0.06 [5/11/2022 4:09 PM] |
1.63 | -0.15 (-8.43%) |
0.0 | 0.0 (0.00%) |
1.62 - 7.42 | 41,891 | 90,000 | 0 | |
15-03-2022 | AH | 4:00 PM ET (Mar 15) |
TCON | TRACON Pharmaceuticals | 57.00 | -0.40 | -0.40 | 0.00 | Tracon GAAP EPS of -$0.40 misses by $0.04 [3/15/2022 4:25 PM] |
2.42 | -0.28 (-10.37%) |
2.35 | -0.35 (-12.96%) |
1.97 - 9.75 | 351,298 | 223,001 | 20,969 | |
03-11-2021 | AH | 4:00 PM ET (Nov 3) |
TCON | TRACON Pharmaceuticals, Inc. | 73.06 | -0.38 | -0.32 | -0.38 | Tracon EPS misses by $0.05 [11/3/2021 4:52 PM] |
3.61 | -0.05 (-1.37%) |
3.66 | 0.0 (0.00%) |
3.21 - 12.20 | 196,941 | 90,000 | 200 | |
11-08-2021 | AH | 4:00 PM ET (Aug 11) |
TCON | TRACON Pharmaceuticals, Inc. | 58.60 | -0.58 | -0.34 | -0.70 | Tracon EPS misses by $0.27 [8/11/2021 4:30 PM] |
3.60 | -0.06 (-1.64%) |
3.66 | 0.0 (0.00%) |
1.55 - 12.20 | 272,359 | 300,000 | 3,713 | |
05-05-2021 | AH | 4:00 PM ET (May 5) |
TCON | TRACON Pharmaceuticals, Inc. | 115.95 | -0.33 | -0.31 | -0.78 | Tracon EPS misses by $0.03 [5/5/2021 4:19 PM] |
6.21 | -0.49 (-7.31%) |
6.50 | -0.20 (-2.99%) |
1.55 - 12.20 | 212,108 | 100,000 | 232 | |
|
||||||||||||||||||
25-02-2021 | AH | 4:00 PM ET (Feb 25) |
TCON | TRACON Pharmaceuticals, Inc. | 138.46 | -0.31 | -0.34 | -1.25 | Tracon EPS beats by $0.10 [2/25/2021 4:06 PM] |
9.27 | 0.27 (3.00%) |
9.20 | 0.20 (2.22%) |
0.95 - 12.20 | 976,347 | 431,946 | 1,747 | |
10-11-2020 | AH | 4:05 PM ET (Nov 10) |
TCON | TRACON Pharmaceuticals, Inc. | 75.54 | -0.38 | -0.61 | -1.70 | Tracon EPS beats by $0.28 [11/10/2020 4:14 PM] |
7.54 | 2.00 (36.10%) |
5.50 | -0.04 (-0.72%) |
0.95 - 7.95 | 11,231,827 | 344,293 | 780 | |
|
||||||||||||||||||
05-08-2020 | AH | 4:00 PM ET (Aug 5) |
TCON | TRACON Pharmaceuticals, Inc. | 9.08 | -0.70 | -0.74 | -2.10 | Tracon EPS beats by $0.03 [8/5/2020 4:17 PM] |
1.86 | -0.10 (-5.36%) |
1.90 | -0.06 (-3.06%) |
0.95 - 6.10 | 320,533 | 586,000 | 12,087 | |
|
||||||||||||||||||
13-05-2020 | AH | 4:00 PM ET (May 13) |
TCON | TRACON Pharmaceuticals, Inc. | 11.00 | -0.78 | -0.99 | -2.40 | Tracon EPS beats by $0.35 [5/13/2020 4:07 PM] |
2.01 | -0.24 (-10.67%) |
1.93 | -0.08 (-3.98%) |
0.95 - 8.90 | 304,572 | 183,971 | 1,782 | |
|